AEON REIT Investment Corp. ( ($JP:3292) ) has provided an update. AEON REIT Investment Corporation announced that its asset ...

Market Capitalization Reflects the total market value of a company. Market Cap is calculated by multiplying the number of shares outstanding by the stock's price. For companies with multiple ...

The reverse stock split is part of AEON's ongoing efforts to meet regulatory requirements and enhance its position in the market. AEON closed Monday's (Feb.24 2025) trading at $0.06 down by 43 ...

AEON Biopharma, Inc. (NYSE: AEON) (the “Company”), a clinical-stage biopharmaceutical company focused on developing a botulinum toxin complex under a 351 (k) biosimilar pathway, today announced that ...

TOKYO -- Aeon is set to turn two of its listed subsidiaries into wholly owned units, Nikkei learned on Friday, in a move aimed at buttressing the mall business as well as addressing investor concerns ...

About AEON Biopharma AEON is a clinical stage biopharmaceutical ... with an initial focus on the neurosciences market. ABP-450 is the same botulinum toxin complex that is currently approved ...

AEON Credit managing director Daisuke Maeda said despite the competition among digital banks, the new product has received positive feedback from depositors. “We have a strong market presence.

Highlights,AEON Biopharma implements 1-for-72 reverse stock split to maintain NYSE compliance.,New split ratio approved by stockholders at February 24 meeting.,Fractional shares rounded up to the ...